| Title: | FDA PUBLIC MEETING NOTICE |
|---|---|
| Date: | 1996-06-19 |
| To: | abi |
| Links: | previous, next |
THE FOLLOWING INFORMATION IS PROVIDED TO ABI FILERS FILING ENTRIES
USING THE FDA INTERFACE. ALL QUESTIONS SHOULD BE DIRECTED TO
DENNIS LINSLEY OF THE FDA, AT 301-443-6553.
IMPORTERS, BROKERS, PRIVATE LABS, TRADE ASSOCIATIONS
THE FOOD AND DRUG ADMINISTRATION, OFFICE OF REGULATORY AFFAIRS IS
CONDUCTING A SERIES OF PUBLIC MEETINGS WITH THE IMPORT, DOMESTIC
AND PRIVATE LABORATORY COMMUNITIES.
MEETING OBJECTIVES:
TO ESTABLISH A DIALOGUE WITH THE IMPORT, DOMESTIC AND PRIVATE
LABORATORY COMMUNITIES, TRADE ASSOCIATIONS AND OTHER INTERESTED
PERSONS ON WAYS THE AGENCY MIGHT IMPROVE CURRENT POLICY AND
PROCEDURES RELATED TO THE USE OF PRIVATE LABORATORY DATA TO
ESTABLISH PRODUCT COMPLIANCE WITH FDA REGULATIONS.
TO OBTAIN INFORMATION AND VIEWS FROM INTERESTED PERSONS, ON WAYS
THE AGENCY MIGHT ENHANCE ITS USE OF PRIVATE LABORATORIES TO
FACILITATE GETTING GOOD PRODUCTS TO THE CONSUMER WHILE REMOVING BAD
PRODUCTS FROM THE MARKETPLACE.
SCHEDULE:
FOUR MEETINGS WILL TAKE PLACE FROM 8:30A.M. TO 4:00 P.M. ON THE
FOLLOWING DATES AND SPECIFIED LOCATIONS
JUNE 25 - FORT HAMILTON COMMUNITY CLUB, BROOKLYN, NY 11209. CONTACT
PERSON: GEORGE WALDEN (718) 965-5300 EXT 5528, FAX (718) 965-5759.
JUNE 28 - SHERATON PLAZA HOTEL, 1500 SAND LAKE ROAD, ORLANDO,
FL 32809, (407) 859-1500. CONTACT PERSON: BARBARA WARD-GROVES,
(404) 347-4001 EXT 5256, FAX (404) 347-4349
JULY 9 - HOUSTON PLAZA HILTON, HOUSTON, TX. CONTACT PERSON MARIE
FALCONE (214) 655-8100 EXT 128, FAX (214) 655-8130
JULY 11 - OAKLAND FEDERAL BUILDING, EDWARD ROYBALL AUDITORIUM,
OAKLAND, CA. CONTACT PERSON: MARK ROH, (510) 637-3980, FAX (510)
637-3977.
THERE IS NO REGISTRATION FEE BUT ADVANCE REGISTRATION IS REQUIRED.
PLEASE FAX INFORMATION DIRECTLY TO FDA CONTACT PERSONS AT THE SITE
WHERE YOU WISH TO ATTEND.
WORKSHOP INFORMATION (OVERVIEW)
THE FOLLOWING WORKSHOPS WILL BE OFFERED AT EACH MEETING. PLEASE
RANK IN ORDER OF PREFERENCE. FOR A DETAILED REGISTRATION
PACKAGE, INDIVIDUALS ATTENDING THE ORLANDO MEETING SHOULD CONTACT
BARBARA WARD-GROVES IMMEDIATELY.
WORKSHOP 1
WHAT PRACTICES, PROCEDURES OR POLICIES SHOULD BE CHANGED SO THAT
PRIVATE SECTOR TESTING EXPEDITES THE REMOVAL OF PRODUCTS WHICH DO
NOT COMPLY WITH FDA REGULATIONS AND THE DISTRIBUTION OF PRODUCTS
WHICH ARE FULLY COMPLIANT?
WORKSHOP 2
HOW SHOULD FDA ENSURE THE COMPETENCY AND PROFICIENCY OF PRIVATE
LABORATORIES TO TEST REGULATED PRODUCTS?
WORKSHOP 3
HOW CAN FDA BEST ENHANCE ITS USE OF PRIVATE LABORATORIES TO TEST
REGULATED PRODUCTS?